Evidence map›Paper›PMID 39560064›Full record

ArticleThe Cochrane database of systematic reviews2024

Virtual reality technology for pain management in advanced cancer.

Katie Flanagan, Victoria Vickerstaff, Pete Wheatstone, Ollie Minton, Mark Taubert, Briony Hudson, Nicola White

Abstract read
In one paragraph

Article in The Cochrane database of systematic reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Katie FlanaganMarie Curie Palliative Care Research Department, Division of Psychiatry, University College London (UCL), London, UK.
Victoria VickerstaffPriment Clinical Trials Unit. Research Department of Primary Care and Population Health, Universitty College London, London, UK.
Pete WheatstoneLeeds, UK.
Ollie MintonPalliative Medicine, University Hospitals Sussex NHS Foundation Trust, Brighton, UK.
Mark TaubertVelindre Cancer Centre, Cardiff, UK.
Briony HudsonPolicy and Research, Marie Curie, London, UK.
Nicola WhiteMarie Curie Palliative Care Research Department, Division of Psychiatry, University College London (UCL), London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primarily, to determine the effectiveness of a virtual reality (VR) intervention compared to an alternative or no intervention for people living with advanced cancer: on pain intensity, adverse events (AEs) and serious adverse events (SAEs); and secondarily, on additional pain properties (e.g. type, frequency), psychological well-being, other physical symptoms (e.g. anxiety) and quality of life. We will also report on the context in which the VR was implemented (setting, type and dose of VR).

Indexed as

Cancer PainPain ManagementHumansNeoplasmsQuality of LifeRandomized Controlled Trials as TopicVirtual RealityVirtual Reality Exposure Therapy

Identifiers

PMID39560064
PMCPMC11574948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.